Background publications
|
Olsen, Wachtell, Beevers, Dahlöf, Devereux, de Faire, Fyhrquist, Ibsen, Kjeldsen, Lederballe-Pedersen, Lindholm, Narayan, Nieminen, Omvik, Oparil, Wedel: "Prognostic importance of hemoglobin in hypertensive patients with electrocardiographic left ventricular hypertrophy: the Losartan Intervention For End point reduction in hypertension (LIFE) study." in: American heart journal, Vol. 157, Issue 1, pp. 177-84, 2008 (PubMed).
Fyhrquist, Saijonmaa: "Renin-angiotensin system revisited." in: Journal of internal medicine, Vol. 264, Issue 3, pp. 224-36, 2008 (PubMed).
Jankowski, Vanholder, van der Giet, Tölle, Karadogan, Gobom, Furkert, Oksche, Krause, Tran, Tepel, Schuchardt, Schlüter, Wiedon, Beyermann, Bader, Todiras, Zidek, Jankowski: "Mass-spectrometric identification of a novel angiotensin peptide in human plasma." in: Arteriosclerosis, thrombosis, and vascular biology, Vol. 27, Issue 2, pp. 297-302, 2007 (PubMed).
Weir, Dzau: "The renin-angiotensin-aldosterone system: a specific target for hypertension management." in: American journal of hypertension, Vol. 12, Issue 12 Pt 3, pp. 205S-213S, 2000 (PubMed).
Goodfriend, Peach: "Angiotensin III: (DES-Aspartic Acid-1)-Angiotensin II. Evidence and speculation for its role as an important agonist in the renin - angiotensin system." in: Circulation research, Vol. 36, Issue 6 Suppl 1, pp. 38-48, 1975 (PubMed).
|